[ad_1] Mumbai-based drug manufacturer Cipla Ltd. has informed the exchanges that its manufacturing facility in Bengaluru’s Virgonagar has received a Voluntary Action Indicated status from the United States Food and Drug Administration (USFDA.) Company Value Change %Change A Voluntary Action Indicated (VAI) status means that objectionable conditions or practices were found at the facility, but […]
Cipla’s Goa facility receives single USFDA observation following inspection – CNBC TV18
[ad_1] Pharma major Cipla Ltd on Monday (January 20) announced that the United States Food and Drug Administration (FDA) conducted an inspection of its wholly-owned subsidiary, Medispray Laboratories Private Ltd, located in Kundaim, Goa, from January 14-20, 2025. Company Value Change %Change “…we hereby notify that United States Food and Drugs Administration (‘USFDA’) has conducted […]